Literature DB >> 14671109

Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.

Vanessa M Hirsch1, Sampa Santra, Simoy Goldstein, Ronald Plishka, Alicia Buckler-White, Aruna Seth, Ilnour Ourmanov, Charles R Brown, Ronald Engle, David Montefiori, Jennifer Glowczwskie, Kevin Kunstman, Steven Wolinsky, Norman L Letvin.   

Abstract

A fraction of simian immunodeficiency virus (SIV)-infected macaques develop rapidly progressive disease in the apparent absence of detectable SIV-specific antibody responses. To characterize the immunopathogenesis of this syndrome, we studied viral load, CD4+ T-lymphocyte numbers as well as cellular and humoral immune responses to SIV and other exogenous antigens in four SIVsm-infected rhesus macaques that progressed to AIDS 9 to 16 weeks postinoculation. Each of these animals exhibited high levels of viremia but showed relatively preserved CD4 T lymphocytes in blood and lymphoid tissues at the time of death. Transient SIV-specific antibody responses and cytotoxic T-lymphocyte responses were observed at 2 to 4 weeks postinoculation. Two of the macaques that were immunized sequentially with tetanus toxoid and hepatitis A virus failed to develop antibody to either antigen. These studies show that the SIV-infected rapid progressor macaques initially mounted an appropriate but transient cellular and humoral immune response. The subsequent immune defect in these animals appeared to be global, affecting both cellular and humoral immunity to SIV as well as immune responses against unrelated antigens. The lack of CD4 depletion and loss of humoral and cellular immune responses suggest that their immune defect may be due to an early loss in T helper function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14671109      PMCID: PMC303408          DOI: 10.1128/jvi.78.1.275-284.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

2.  Highly active antiretroviral therapy restores in vitro mitogen and antigen-specific T-lymphocyte responses in HIV-1 perinatally infected children despite virological failure.

Authors:  M Peruzzi; C Azzari; L Galli; A Vierucci; M De Martino
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

Review 3.  Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques.

Authors:  N L Letvin; N W King
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

4.  Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.

Authors:  A Watson; J Ranchalis; B Travis; J McClure; W Sutton; P R Johnson; S L Hu; N L Haigwood
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia.

Authors:  J Y Zhang; L N Martin; E A Watson; R C Montelaro; M West; L Epstein; M Murphey-Corb
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

6.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

7.  Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.

Authors:  M S Orandle; K C Williams; A G MacLean; S V Westmoreland; A A Lackner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.

Authors:  G Pantaleo; S Menzo; M Vaccarezza; C Graziosi; O J Cohen; J F Demarest; D Montefiori; J M Orenstein; C Fox; L K Schrager
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

9.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

10.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

View more
  25 in total

1.  Persistent transcription of a nonintegrating mutant of simian immunodeficiency virus in rhesus macrophages.

Authors:  Yanfang Zheng; Ilnour Ourmanov; Vanessa M Hirsch
Journal:  Virology       Date:  2007-12-03       Impact factor: 3.616

2.  Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.

Authors:  Takeo Kuwata; Houman Dehghani; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Tatsuhiko Igarashi; Joseph Mattapallil; Mario Roederer; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Adaptive evolution of simian immunodeficiency viruses isolated from 2 conventional-progressor macaques with encephalitis.

Authors:  Que Dang; Robert M Goeken; Charles R Brown; Ronald J Plishka; Alicia Buckler-White; Russell Byrum; Brian T Foley; Vanessa M Hirsch
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

4.  Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates.

Authors:  Simoy Goldstein; Ilnour Ourmanov; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Russell Byrum; Vanessa M Hirsch
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS.

Authors:  Charles R Brown; Meggan Czapiga; Juraj Kabat; Que Dang; Ilnour Ourmanov; Yoshiaki Nishimura; Malcolm A Martin; Vanessa M Hirsch
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques.

Authors:  Yin Xu; Chris Weatherall; Michelle Bailey; Sheilajen Alcantara; Robert De Rose; Jerome Estaquier; Kim Wilson; Kazuo Suzuki; Jacques Corbeil; David A Cooper; Stephen J Kent; Anthony D Kelleher; John Zaunders
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

7.  Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses.

Authors:  Yoshiaki Nishimura; Tatsuhiko Igarashi; Olivia K Donau; Alicia Buckler-White; Charles Buckler; Bernard A P Lafont; Robert M Goeken; Simoy Goldstein; Vanessa M Hirsch; Malcolm A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

8.  IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.

Authors:  Yvonne M Mueller; Duc H Do; Susan R Altork; Carol M Artlett; Edward J Gracely; Christos D Katsetos; Agustin Legido; Francois Villinger; John D Altman; Charles R Brown; Mark G Lewis; Peter D Katsikis
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

9.  A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses.

Authors:  Takeo Kuwata; Russell Byrum; Sonya Whitted; Robert Goeken; Alicia Buckler-White; Ronald Plishka; Ranjini Iyengar; Vanessa M Hirsch
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

10.  Association of progressive CD4(+) T cell decline in SIV infection with the induction of autoreactive antibodies.

Authors:  Takeo Kuwata; Yoshiaki Nishimura; Sonya Whitted; Ilnour Ourmanov; Charles R Brown; Que Dang; Alicia Buckler-White; Ranjini Iyengar; Jason M Brenchley; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.